SABCS 2023 | Potential applications of ctDNA fragmentation patterns in HER2- BC

Marina N. Sharifi, MD, University of Wisconsin Carbone Cancer Center, Madison, WI, shares her thoughts on the potential applications of ctDNA fragmentation patterns in guiding therapeutic strategies for metastatic HER2-negative breast cancer patients. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.